Retrospective Cohort Comparison of Gonadotropin versus follicle-stimulating hormone for in ovarian response patients undergoing in vitro fertilization
Conclusionshp-HMG and rFSH did not lead to significantly different treatment outcomes in POR patients undergoing IVF/ISCI with a GnRH antagonist protocol, although significantly higher serum IGF-1 level and insignificantly lower serum IGFBP-1 level on the day of oocyte retrieval associated with hp-HMG might suggest a beneficial endocrine environment.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Environmental Health | Hormones | ICSI (Intracytoplasmic Sperm Injection) | Insulin | Men | Menopause | Miscarriage | Ovaries | Pregnancy | Statistics | Study